Article
Mast cell sarcoma with KIT p.D816V mutation and concurrent systemic mastocytosis.
Journal of hematopathology - 1 Dec 2024
Collins Nicholas, Willard Nicholas, Pan Zenggang
Abstract excerpt
Mast cell sarcoma (MCS) is an extremely rare and aggressive form of mastocytosis characterized by highly atypical mast cells with local invasion, metastatic potential, and poor prognosis. MCS is predominantly a de novo process without recurrent molecular findings or predisposing lesions including various myeloid neoplasms. However, there have been rare case reports of MCS with preceding or concurrent systemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
